Curaleaf has been losing ground for 3 days, shedding a total of 6.35% of its value. Similar trend today: Curaleaf is down to $3.69, after ending yesterday at $3.74. Overall, a 1.34% loss or 5 cents today.
United States FOMC Meeting Minutes is next today at 19:00 UTC.
Meanwhile, United States Existing Home Sales (Jan) came out at 4 million, while a consensus of analysts was expecting 4 million. United States 2-Year Note Auction released yesterday at 18:00 UTC with a figure of 4.673, while the previous figure was 4.139. United States Existing Home Sales released earlier showed a marked improvement to -0.7% from the preceding data of -2.2%, but fell short of the 2% figure forecast by a consensus of market analysts.
Curaleaf Holdings, Inc.'s lower Bollinger Band® is at $3.62, indicating that the asset has overextended to the downside and could, therefore, bounce back as buyers look for bargains.
Technical analysis indicates that Curaleaf (currently on a downtrend) might reverse course and start pointing upward in the short term.
Curaleaf's stock value drop coincides with after closing the previous session (yesterday) at $152, AbbVie lost $1.71 and is trading around $150.29.
Positive performances can be seen by looking at other health care stocks as Eli Lilly and Company gained 0.79%, currently at $330.1.
With markets struggling for positive sentiment, upcoming macro data could potentially attract buyers in the market as tomorrow at 16:00 UTC data for United States Crude Oil Inventories will be released, with an expected decline to 1.17 million from the preceding figure of 16.28 million. Projections for United States Initial Jobless Claims are set for a continuation of decline with 200,000 while previous data was 194,000; data will be released tomorrow at 13:30 UTC.
Furthermore, United States GDP figure is projected at 2.9. It previously stood at 2.9; data will be released tomorrow at 13:30 UTC.
Trending downwards for around 2 months. The leading medical and recreational marijuana dispensary has shed 41.56% over the past three months.